These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4830046)

  • 1. [Effect of antibiotics and an immune organism on the causative agent of brucellosis].
    Taran IF; Zamakhaeva EI; Kozlov MP; Pogorelov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):78-82. PubMed ID: 4830046
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of a Brucella vaccine strain of low residual virulence by chemical mutagenesis.
    Zhao WR; Wendoso ; Hasi ; Qin YX; Weng W; Lu SL
    J Med Microbiol; 1989 Oct; 30(2):143-8. PubMed ID: 2795638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response of guinea pigs to combined action of brucella vaccine and homologous lysed antigen].
    Rementsova MM; Shin NG; Usmanova FI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Mar; (3):72-5. PubMed ID: 6774529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a Brucella vaccine for humans.
    Perkins SD; Smither SJ; Atkins HS
    FEMS Microbiol Rev; 2010 May; 34(3):379-94. PubMed ID: 20180858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphologic reactions in brucella infections in guinea pigs prevaccinated with cellular components of virulent brucellea].
    Safronova VM; Baeva AA; Taran IF
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (3):73-6. PubMed ID: 822661
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory animal models for brucellosis research.
    Silva TM; Costa EA; Paixão TA; Tsolis RM; Santos RL
    J Biomed Biotechnol; 2011; 2011():518323. PubMed ID: 21403904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to brucella infection.
    Elberg SS
    Medicine (Baltimore); 1973 Jul; 52(4):339-56. PubMed ID: 4198657
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunobiology of brucellosis].
    Parnas J
    Arzneimittelforschung; 1973 Jan; 23(1):103. PubMed ID: 4125094
    [No Abstract]   [Full Text] [Related]  

  • 9. [Human brucellosis. Present state of the clinical course, diagnosis and prophylaxis].
    Parnas J
    Munch Med Wochenschr; 1967 Aug; 109(31):1628-32. PubMed ID: 5631558
    [No Abstract]   [Full Text] [Related]  

  • 10. [Jet method of administration of live brucella vaccine].
    Kniazeva ZN; Shavalov LP; Vermul MS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):27-30. PubMed ID: 99922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenic properties of brucella protective antigen upon revaccination].
    Dranovskaia EA; Vershilova PA
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):94-9. PubMed ID: 828826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brucella at the dawn of the third milenium: genomic organization and pathogenesis].
    Michaux-Charachon S; Foulongne V; O'Callaghan D; Ramuz M
    Pathol Biol (Paris); 2002 Jul; 50(6):401-12. PubMed ID: 12168259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined immunization with live vaccines from brucellae of the 3 principal species].
    Kozlov MP; Zamakhaeva EI
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):124-7. PubMed ID: 4995251
    [No Abstract]   [Full Text] [Related]  

  • 15. [The possibility of creating a vaccinal strain of Brucella abortus 19-BA with multiple antibiotic resistance].
    Gorelov VN; Gubina EA; Grekova NA; Skavronskaia AG
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):2-4. PubMed ID: 1759514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response of guinea pigs and buffalo calves to the locally prepared Brucella abortus strain 19 vaccine.
    Jamal SM; Afzal M; Ahmed S
    Rev Sci Tech; 2003 Dec; 22(3):893-7. PubMed ID: 15005547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience with the vaccine-drug therapy of brucellosis accompanied by changes in the state of allergic reactivity].
    Lopatina ZhM
    Sov Med; 1973 May; 36(5):72-6. PubMed ID: 4543750
    [No Abstract]   [Full Text] [Related]  

  • 18. [Distribution in a sensitized organism of corpuscular and lysed antigens labelled with radioactive isotopes].
    Beklemishev ND; Shaposhnikov EM; Ezhina Ch
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Feb; 48(2):80-3. PubMed ID: 5581225
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of pre-existing immunity to one of the antigens of associated plague, tularemia, brucellosis vaccine on the immunizing properties of its other components. II. Immunologic reorganization in complex vaccination against plague, tularemia and brucellosis following preliminary vaccination with live tularemia vaccine].
    Pilipenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Nov; 43(11):43-8. PubMed ID: 6004968
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs.
    Lalsiamthara J; Senevirathne A; Lee JH
    Vaccine; 2019 Feb; 37(7):899-902. PubMed ID: 30661832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.